4.7 Review

Next-Generation Probiotics for Inflammatory Bowel Disease

期刊

出版社

MDPI
DOI: 10.3390/ijms23105466

关键词

probiotics; bioengineering; inflammatory bowel disease; biosensors; biotherapeutics

向作者/读者索取更多资源

Engineered probiotics are a cutting-edge therapy in treating intestinal inflammatory diseases, offering a new strategy with therapeutically operative molecules. Traditional treatments have side effects, prompting the search for new and effective therapies as a global goal in research.
Engineered probiotics represent a cutting-edge therapy in intestinal inflammatory disease (IBD). Genetically modified bacteria have provided a new strategy to release therapeutically operative molecules in the intestine and have grown into promising new therapies for IBD. Current IBD treatments, such as corticosteroids and immunosuppressants, are associated with relevant side effects and a significant proportion of patients are dependent on these therapies, thus exposing them to the risk of relevant long-term side effects. Discovering new and effective therapeutic strategies is a worldwide goal in this research field and engineered probiotics could potentially provide a viable solution. This review aims at describing the proceeding of bacterial engineering and how genetically modified probiotics may represent a promising new biotechnological approach in IBD treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据